1652 — Fusen Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Fusen Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Short Term Investments
Cash and Short Term Investments	81.7	133	36.1	21.1	83.8
Net Total Accounts Receivable
Net Total Receivables	259	311	328	277	209
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	509	614	567	460	495
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	506	530	562	621	550
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,239	1,350	1,344	1,238	1,263
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	489	722	665	772	877
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	581	736	780	868	904
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	658	614	564	370	359
Total Liabilities & Shareholders' Equity	1,239	1,350	1,344	1,238	1,263
Total Common Shares Outstanding